title: Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Reyes
authors.forename: Pedro
authors.initials: P
authors.lastname: Jaén
authors.forename: Elena
authors.initials: E
authors.lastname: de las Heras
authors.forename: Flavio
authors.initials: F
authors.lastname: Carrión
authors.forename: Melchor
authors.initials: M
authors.lastname: Alvarez-Mon
authors.forename: Ester
authors.initials: E
authors.lastname: de Eusebio
authors.forename: M
authors.initials: M
authors.lastname: Alvare
authors.forename: Jesús
authors.initials: J
authors.lastname: Cuevas
authors.forename: Salvador
authors.initials: S
authors.lastname: González
authors.forename: Vicente G
authors.initials: VG
authors.lastname: Villarrubia
mesh_terms: D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008027:Light; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D010865:Pilot Projects; D010919:Placebos; D032494:Polypodium / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism; D013997:Time Factors; D016896:Treatment Outcome; D014820:Vitiligo / Q000628:therapy*
chemical_list: D007166:Immunosuppressive Agents; D010919:Placebos